Ryman Hospitality Properties Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Ryman Hospitality Properties Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||
net income | 75,875,000 | 63,014,000 | 72,291,000 | 60,398,000 | 104,740,000 | 42,761,000 | 169,878,000 | 40,785,000 | 70,143,000 | 60,994,000 | 61,370,000 | 47,451,000 | 50,924,000 | -24,797,000 | -6,024,000 | -8,607,000 | -63,049,000 | -117,121,000 | -92,549,000 | -129,877,000 | -187,659,000 | -50,736,000 | 38,450,000 | 20,890,000 | 46,284,000 | 22,670,000 | 159,194,000 | 22,591,000 | 55,546,000 | 27,339,000 | 72,318,000 | 23,870,000 | 47,292,000 | 32,620,000 |
amounts to reconcile net income to net cash flows from operating activities: | ||||||||||||||||||||||||||||||||||
benefit from deferred income taxes | 51,000 | 1,463,000 | 3,699,000 | 4,250,000 | -1,985,000 | 818,000 | 1,392,000 | 3,781,000 | -81,000 | -34,000 | 82,000 | 26,559,000 | 2,678,000 | |||||||||||||||||||||
depreciation and amortization | 66,963,000 | 63,717,000 | 60,820,000 | 59,051,000 | 58,553,000 | 57,202,000 | 56,527,000 | 58,086,000 | 48,257,000 | 48,357,000 | 47,904,000 | 47,969,000 | 56,715,000 | 56,028,000 | 56,276,000 | 56,093,000 | 54,673,000 | 53,315,000 | 53,850,000 | 53,876,000 | 54,011,000 | 53,345,000 | 53,287,000 | 53,998,000 | 53,553,000 | 53,009,000 | 31,221,000 | 30,994,000 | 29,995,000 | 28,666,000 | 28,097,000 | 28,546,000 | 27,679,000 | 27,637,000 |
amortization of deferred financing costs | 2,900,000 | 2,707,000 | 2,660,000 | 2,647,000 | 2,627,000 | 2,721,000 | 2,674,000 | 2,682,000 | 2,633,000 | 2,674,000 | 2,651,000 | 2,640,000 | 2,309,000 | 2,229,000 | 2,211,000 | 2,200,000 | 2,170,000 | 2,209,000 | 2,059,000 | 2,038,000 | 1,957,000 | 1,894,000 | 1,857,000 | 1,939,000 | 1,939,000 | 1,927,000 | 1,395,000 | 1,396,000 | 1,426,000 | 1,415,000 | 1,392,000 | 1,391,000 | 1,304,000 | 1,263,000 |
(income) income from unconsolidated joint ventures | 13,000 | 16,000 | -51,000 | -9,000 | -183,000 | -32,000 | ||||||||||||||||||||||||||||
equity-based compensation expense | 3,495,000 | 3,622,000 | ||||||||||||||||||||||||||||||||
changes in: | ||||||||||||||||||||||||||||||||||
trade receivables | 15,488,000 | -36,536,000 | 13,118,000 | 19,980,000 | -1,669,000 | -15,584,000 | 8,317,000 | -13,136,000 | 56,748,000 | -30,379,000 | 14,660,000 | -6,096,000 | -40,762,000 | -8,488,000 | -1,709,000 | -36,099,000 | -18,654,000 | 1,823,000 | -6,449,000 | 4,713,000 | 60,582,000 | -8,345,000 | 12,400,000 | 7,365,000 | 19,441,000 | -42,050,000 | 14,655,000 | -901,000 | -13,341,000 | -8,733,000 | -837,000 | 8,893,000 | 1,258,000 | -19,016,000 |
accounts payable and accrued liabilities | -48,970,000 | -16,381,000 | -6,242,000 | 95,108,000 | 4,048,000 | -79,054,000 | 29,799,000 | 77,767,000 | -9,752,000 | -56,294,000 | 22,334,000 | 20,160,000 | 41,264,000 | -17,330,000 | 33,642,000 | 37,543,000 | 40,612,000 | -4,785,000 | -2,804,000 | 52,797,000 | -83,524,000 | -26,297,000 | 6,231,000 | 13,020,000 | -50,557,000 | 17,632,000 | -12,478,000 | 38,947,000 | 7,117,000 | -11,385,000 | -14,805,000 | 43,384,000 | -3,129,000 | -8,261,000 |
other assets and liabilities | 199,000 | 15,127,000 | 21,382,000 | -22,619,000 | 1,670,000 | -3,915,000 | 16,927,000 | -29,726,000 | 7,144,000 | -953,000 | 14,873,000 | -4,431,000 | 13,972,000 | -17,814,000 | -120,000 | -6,972,000 | -7,207,000 | 13,760,000 | -6,332,000 | 3,164,000 | 690,000 | -1,702,000 | 4,919,000 | -12,415,000 | 4,215,000 | -1,754,000 | 4,987,000 | -7,427,000 | -2,204,000 | 2,924,000 | 8,928,000 | -5,592,000 | -1,444,000 | 2,696,000 |
net cash flows from operating activities | 122,500,000 | 98,219,000 | 166,626,000 | 218,086,000 | 184,321,000 | 7,473,000 | 187,127,000 | 154,427,000 | 183,791,000 | 31,711,000 | 173,961,000 | 118,357,000 | 88,583,000 | -42,887,000 | -49,193,000 | -1,530,000 | -115,472,000 | 4,671,000 | 123,545,000 | 92,517,000 | 84,064,000 | 54,560,000 | 96,643,000 | 93,561,000 | 87,787,000 | 43,928,000 | 80,060,000 | 101,862,000 | 75,587,000 | 38,321,000 | ||||
| ||||||||||||||||||||||||||||||||||
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||
purchases of property and equipment | -69,511,000 | -112,727,000 | -90,582,000 | -132,387,000 | -105,506,000 | -79,430,000 | -84,626,000 | -43,977,000 | -41,402,000 | -36,771,000 | -41,301,000 | -23,504,000 | -14,999,000 | -9,716,000 | -11,264,000 | -12,669,000 | -27,662,000 | -25,831,000 | -40,882,000 | -41,442,000 | -39,971,000 | -43,168,000 | -42,938,000 | -40,529,000 | -20,201,000 | -48,873,000 | -55,413,000 | -37,451,000 | -47,765,000 | -47,588,000 | -55,417,000 | -47,676,000 | -41,762,000 | -37,710,000 |
purchase of jw marriott desert ridge, net of cash acquired | ||||||||||||||||||||||||||||||||||
other investing activities | -209,000 | -18,400,000 | -6,396,000 | -198,000 | -142,000 | 179,000 | 21,000 | 6,000 | -88,000 | -9,916,000 | 1,000 | 20,000 | 2,000 | 816,000 | 72,000 | 20,000 | 0 | 5,462,000 | 2,000 | -2,995,000 | 687,000 | 1,004,000 | 779,000 | 2,518,000 | -2,053,000 | -229,000 | -1,776,000 | 1,096,000 | -2,032,000 | -2,655,000 | -3,095,000 | 1,484,000 | -2,932,000 | -2,691,000 |
net cash flows used in investing activities | -931,678,000 | -131,127,000 | -96,978,000 | -128,525,000 | -105,648,000 | -79,251,000 | -84,605,000 | -42,711,000 | -836,956,000 | -48,544,000 | -41,451,000 | -26,266,000 | -113,032,000 | -8,564,000 | -12,734,000 | -14,354,000 | -237,709,000 | -24,941,000 | -40,987,000 | -43,485,000 | -42,922,000 | -45,254,000 | -59,159,000 | -42,968,000 | -11,808,000 | -49,102,000 | -280,768,000 | -36,355,000 | -54,384,000 | -51,803,000 | -67,456,000 | -52,539,000 | -40,665,000 | -53,852,000 |
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||
borrowings under term loan b | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
repayments under term loan b | -734,000 | -734,000 | -734,000 | -737,000 | -19,599,000 | -201,250,000 | -1,250,000 | -1,250,000 | -375,000,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -1,250,000 | -101,250,000 | -2,500,000 | -2,500,000 | -1,250,000 | -1,250,000 | -1,250,000 | ||||||
borrowings under oeg revolving credit facility | 0 | 5,000,000 | 11,000,000 | 4,000,000 | 0 | 7,000,000 | ||||||||||||||||||||||||||||
repayments under oeg revolving credit facility | -17,000,000 | -9,000,000 | -6,000,000 | -5,000,000 | ||||||||||||||||||||||||||||||
borrowings under oeg term loan | 0 | 0 | ||||||||||||||||||||||||||||||||
repayments under oeg term loan | -1,077,000 | -750,000 | -750,000 | 0 | -295,500,000 | -750,000 | -750,000 | -750,000 | -750,000 | -750,000 | ||||||||||||||||||||||||
repayments under block 21 cmbs loan | -128,185,000 | -782,000 | -751,000 | -721,000 | -711,000 | -721,000 | -711,000 | -681,000 | -671,000 | -702,000 | -673,000 | -642,000 | ||||||||||||||||||||||
repayments under gaylord rockies term loan | 0 | 0 | 0 | -800,000,000 | ||||||||||||||||||||||||||||||
issuance of senior notes | 0 | 0 | 0 | 1,000,000,000 | 0 | 0 | 0 | 0 | 0 | 600,000,000 | 202,500,000 | |||||||||||||||||||||||
deferred financing costs paid | -575,000 | -72,000 | -6,247,000 | -16,815,000 | 0 | 279,000 | -199,000 | -462,000 | 0 | 0 | -88,000 | -10,540,000 | -686,000 | -18,000 | -1,404,000 | -106,000 | -10,079,000 | -17,560,000 | 0 | -5,000 | 0 | -48,000 | ||||||||||||
issuance of common stock | 0 | 0 | ||||||||||||||||||||||||||||||||
payment of distributions | -69,463,000 | -70,258,000 | -66,355,000 | -66,329,000 | -66,295,000 | -67,135,000 | ||||||||||||||||||||||||||||
payment of tax withholdings for share-based compensation | -31,000 | -5,441,000 | -169,000 | -25,000 | -14,000 | -12,092,000 | -137,000 | -69,000 | -100,000 | -4,080,000 | -117,000 | -476,000 | -124,000 | -3,761,000 | -57,000 | -21,000 | -50,000 | -3,357,000 | 0 | -28,000 | -29,000 | -1,631,000 | -24,000 | -89,000 | -63,000 | -3,813,000 | -43,000 | -350,000 | -3,169,000 | -602,000 | -35,000 | -6,000 | -28,000 | -3,741,000 |
other financing activities | -1,040,000 | -30,000 | -17,000 | -25,000 | -21,000 | -18,000 | -73,000 | -59,000 | -55,000 | -84,000 | -42,000 | -44,000 | -47,000 | -66,000 | -45,000 | -58,000 | -55,000 | -58,000 | -57,000 | -45,000 | -52,000 | -91,000 | -94,000 | -7,255,000 | 5,501,000 | 1,605,000 | -5,000 | -4,000 | -6,000 | 32,000 | -5,000 | -5,000 | 23,000 | |
net cash flows from financing activities | -64,351,000 | -68,909,000 | -58,061,000 | -69,645,000 | -8,883,000 | -3,157,000 | 68,105,000 | -5,353,000 | 8,648,000 | -46,332,000 | 223,546,000 | 75,869,000 | 346,844,000 | -7,731,000 | 14,892,000 | |||||||||||||||||||
net change in cash, cash equivalents, and restricted cash | -10,620,000 | -114,903,000 | 5,297,000 | 20,652,000 | 3,397,000 | -153,559,000 | 44,461,000 | 42,071,000 | 200,284,000 | -30,705,000 | 123,627,000 | 88,934,000 | 86,860,000 | -18,091,000 | 84,497,000 | -10,122,000 | 830,000 | 8,041,000 | -21,179,000 | -36,366,000 | -589,358,000 | 306,261,000 | 260,937,000 | -9,635,000 | 22,278,000 | -2,273,000 | 24,692,000 | 30,437,000 | 8,233,000 | 7,017,000 | ||||
cash, cash equivalents, and restricted cash, beginning of period | 0 | 576,228,000 | 0 | 0 | 700,441,000 | 0 | 0 | 444,330,000 | 0 | 0 | 0 | 163,000,000 | 0 | 0 | 0 | 79,754,000 | 0 | 0 | 0 | 420,396,000 | 0 | 0 | 0 | 149,089,000 | 0 | 0 | 0 | 78,710,000 | ||||||
cash, cash equivalents, and restricted cash, end of period | -10,620,000 | 461,325,000 | 20,652,000 | 3,397,000 | 546,882,000 | 42,071,000 | 200,284,000 | 413,625,000 | 123,627,000 | 88,934,000 | 86,860,000 | 144,909,000 | 84,497,000 | -10,122,000 | 830,000 | 87,795,000 | -21,179,000 | -36,366,000 | -589,358,000 | 726,657,000 | 260,937,000 | -9,635,000 | 22,278,000 | 146,816,000 | 24,692,000 | 30,437,000 | 8,233,000 | 85,727,000 | ||||||
reconciliation of cash, cash equivalents, and restricted cash to balance sheet: | ||||||||||||||||||||||||||||||||||
cash and cash equivalents - unrestricted | 6,721,000 | 413,858,000 | -57,237,000 | 36,560,000 | 33,060,000 | 465,311,000 | 48,757,000 | 34,732,000 | 189,832,000 | 318,512,000 | 109,498,000 | 45,466,000 | 50,794,000 | 128,436,000 | 87,533,000 | -18,457,000 | 4,474,000 | 67,138,000 | 4,535,000 | -30,214,000 | -579,780,000 | 662,156,000 | 260,644,000 | -2,056,000 | 8,969,000 | 94,873,000 | 17,412,000 | 59,040,000 | ||||||
cash and cash equivalents - restricted | -17,341,000 | 47,467,000 | 62,534,000 | -15,908,000 | -29,663,000 | 81,571,000 | -4,296,000 | 7,339,000 | 10,452,000 | 95,113,000 | 14,129,000 | 43,468,000 | 36,066,000 | 16,473,000 | -3,036,000 | 8,335,000 | -3,644,000 | 20,657,000 | -25,714,000 | -6,152,000 | -9,578,000 | 64,501,000 | 293,000 | -7,579,000 | 13,309,000 | 51,943,000 | 7,280,000 | 26,687,000 | ||||||
benefit for deferred income taxes | 2,933,000 | -488,000 | 767,000 | -415,000 | 1,100,000 | 1,599,000 | 1,526,000 | 5,286,000 | 1,779,000 | -52,137,000 | -371,000 | 58,000 | -187,000 | |||||||||||||||||||||
net cash flows used in financing activities | -81,995,000 | -81,781,000 | -13,872,000 | 8,649,000 | -59,184,000 | -26,769,000 | -17,719,000 | -36,261,000 | -19,291,000 | -9,618,000 | ||||||||||||||||||||||||
stock-based compensation expense | 3,167,000 | 3,479,000 | 3,383,000 | 3,862,000 | 3,941,000 | 3,940,000 | 3,801,000 | 3,739,000 | 3,851,000 | 3,694,000 | 3,654,000 | 3,786,000 | 3,160,000 | 3,276,000 | 3,146,000 | 2,522,000 | 2,109,000 | 2,204,000 | 2,189,000 | 2,230,000 | 1,971,000 | 1,901,000 | 1,935,000 | 2,026,000 | 1,832,000 | 1,895,000 | 2,006,000 | 1,923,000 | 1,686,000 | 1,741,000 | 1,644,000 | 1,569,000 | ||
collection of notes receivable | 0 | 0 | 3,760,000 | 0 | 2,143,000 | 0 | 1,337,000 | 0 | 2,381,000 | 0 | 0 | 0 | 2,765,000 | |||||||||||||||||||||
purchase of jw marriott hill country, net of cash acquired | ||||||||||||||||||||||||||||||||||
purchase of block 21, net of cash acquired | 0 | 0 | ||||||||||||||||||||||||||||||||
investment in circle | 0 | -2,500,000 | -4,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||
repayments under revolving credit facility | ||||||||||||||||||||||||||||||||||
repayments under term loan a | 0 | 0 | ||||||||||||||||||||||||||||||||
sale of noncontrolling interest in oeg | -293,000 | -271,000 | ||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, beginning of year | ||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, end of year | ||||||||||||||||||||||||||||||||||
net borrowings under oeg revolving credit facility | 17,000,000 | |||||||||||||||||||||||||||||||||
income from unconsolidated joint ventures | -217,000 | 12,566,000 | 2,153,000 | 2,806,000 | 2,619,000 | 2,720,000 | 3,001,000 | 2,627,000 | 3,132,000 | 2,312,000 | 1,910,000 | 1,609,000 | 1,767,000 | 1,820,000 | 1,895,000 | |||||||||||||||||||
purchase of land adjacent to gaylord rockies | 0 | 0 | ||||||||||||||||||||||||||||||||
purchase of additional interest in gaylord rockies joint venture | 0 | 0 | ||||||||||||||||||||||||||||||||
net borrowings (repayments) under revolving credit facility | 0 | 0 | -106,000,000 | 71,000,000 | -223,000,000 | 255,000,000 | 18,500,000 | 24,000,000 | 56,500,000 | 24,500,000 | 6,000,000 | |||||||||||||||||||||||
redemption of senior notes | 0 | 0 | 0 | -400,000,000 | 0 | |||||||||||||||||||||||||||||
redemption of noncontrolling interest in operating partnership | 0 | 0 | 0 | -2,438,000 | ||||||||||||||||||||||||||||||
purchase of hill country, net of cash acquired | 0 | |||||||||||||||||||||||||||||||||
net repayments under revolving credit facility | ||||||||||||||||||||||||||||||||||
payment of dividends | -60,115,000 | -41,740,000 | -14,006,000 | -5,559,000 | -12,000 | -8,000 | -276,000 | 0 | -3,000 | -11,000 | -488,000 | -6,000 | -10,000 | -52,237,000 | -50,078,000 | -46,309,000 | -46,313,000 | -46,304,000 | -44,420,000 | -43,646,000 | -43,659,000 | -44,110,000 | -41,000,000 | -40,966,000 | -40,952,000 | -40,888,000 | -38,900,000 | |||||||
net borrowings under revolving credit facility | -45,000,000 | -375,000,000 | 400,000,000 | -6,000,000 | 10,000,000 | |||||||||||||||||||||||||||||
credit loss on held-to-maturity securities | 0 | 7,811,000 | 19,145,000 | 5,828,000 | ||||||||||||||||||||||||||||||
forfeiture of block 21 earnest deposit | ||||||||||||||||||||||||||||||||||
write-off of deferred financing costs | 35,000 | 11,000 | 246,000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
investment in other joint ventures | -151,000 | -4,119,000 | -1,542,000 | -2,549,000 | -47,000 | -4,572,000 | -107,000 | -2,033,000 | -3,638,000 | -3,090,000 | -2,000,000 | 0 | -639,000 | -1,560,000 | -2,494,000 | |||||||||||||||||||
distributions from consolidated joint venture to noncontrolling interest partners | 0 | 0 | ||||||||||||||||||||||||||||||||
borrowings under oeg term loan b | 0 | |||||||||||||||||||||||||||||||||
amounts to reconcile net income to net cash flows used in operating activities: | ||||||||||||||||||||||||||||||||||
net cash flows used in operating activities | -4,174,000 | |||||||||||||||||||||||||||||||||
investment in joint ventures | -2,045,000 | |||||||||||||||||||||||||||||||||
earnest money deposit for potential block 21 acquisition | ||||||||||||||||||||||||||||||||||
borrowings under term loan a | 0 | 0 | ||||||||||||||||||||||||||||||||
borrowing under gaylord rockies term loan | 0 | |||||||||||||||||||||||||||||||||
repayment of gaylord rockies construction and mezzanine loans | 0 | |||||||||||||||||||||||||||||||||
impairment charges | ||||||||||||||||||||||||||||||||||
purchase of additional interest in gaylord rockies joint venture, net of cash acquired | 0 | |||||||||||||||||||||||||||||||||
purchase of remaining interest in opry city stage, net of cash acquired | ||||||||||||||||||||||||||||||||||
forfeiture of block21 earnest deposit | 0 | |||||||||||||||||||||||||||||||||
borrowing under gaylord rockies construction and mezzanine loans | ||||||||||||||||||||||||||||||||||
net impairment loss recognized in earnings on held-to-maturity securities | ||||||||||||||||||||||||||||||||||
investment in gaylord rockies joint venture | 0 | 0 | 0 | -16,309,000 | ||||||||||||||||||||||||||||||
income from joint ventures | 308,000 | |||||||||||||||||||||||||||||||||
distribution from consolidated joint venture to noncontrolling interest partners | -95,202,000 | |||||||||||||||||||||||||||||||||
borrowings under gaylord rockies construction and mezzanine loans | 8,756,000 | 28,897,000 | ||||||||||||||||||||||||||||||||
(income) income from joint ventures | ||||||||||||||||||||||||||||||||||
other equity investments in joint ventures | ||||||||||||||||||||||||||||||||||
proceeds from sale of peterson loi | ||||||||||||||||||||||||||||||||||
repayment of note payable related to purchase of ac hotel | ||||||||||||||||||||||||||||||||||
repurchase of company stock for retirement | ||||||||||||||||||||||||||||||||||
impairment and other charges | ||||||||||||||||||||||||||||||||||
purchase of remaining interest in opry city stage | 0 | |||||||||||||||||||||||||||||||||
cash and cash equivalents—unrestricted | ||||||||||||||||||||||||||||||||||
cash and cash equivalents—restricted | ||||||||||||||||||||||||||||||||||
loss on repurchase of warrants | ||||||||||||||||||||||||||||||||||
increase in restricted cash and cash equivalents | -6,450,000 | 472,000 | 4,029,000 | 2,858,000 | ||||||||||||||||||||||||||||||
repurchase of common stock warrants | ||||||||||||||||||||||||||||||||||
net change in cash and cash equivalents | -5,115,000 | 13,062,000 | 15,631,000 | -25,149,000 | ||||||||||||||||||||||||||||||
cash and cash equivalents—unrestricted, beginning of period | ||||||||||||||||||||||||||||||||||
cash and cash equivalents—unrestricted, end of period | ||||||||||||||||||||||||||||||||||
cash and cash equivalents - unrestricted, beginning of period | 0 | 0 | 59,128,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents - unrestricted, end of period | 13,062,000 | 15,631,000 | 33,979,000 | |||||||||||||||||||||||||||||||
net borrowings under credit facility | 33,000,000 | |||||||||||||||||||||||||||||||||
amortization of discount on convertible notes | ||||||||||||||||||||||||||||||||||
(gain) loss on sales of long-lived assets | ||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | ||||||||||||||||||||||||||||||||||
interest receivable | ||||||||||||||||||||||||||||||||||
purchase of ac hotel | ||||||||||||||||||||||||||||||||||
net borrowings (repayments) under credit facility | ||||||||||||||||||||||||||||||||||
net borrowings (repayments) under term loan b | ||||||||||||||||||||||||||||||||||
repurchase and conversion of convertible notes | ||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options | ||||||||||||||||||||||||||||||||||
payment of dividend | ||||||||||||||||||||||||||||||||||
early redemption of senior notes | ||||||||||||||||||||||||||||||||||
proceeds from exercise of stock option and purchase plans | ||||||||||||||||||||||||||||||||||
net repayments under credit facility | ||||||||||||||||||||||||||||||||||
borrowings (repayments) under term loan b | ||||||||||||||||||||||||||||||||||
cash and cash equivalents – unrestricted, beginning of period | ||||||||||||||||||||||||||||||||||
cash and cash equivalents – unrestricted, end of period | ||||||||||||||||||||||||||||||||||
income from unconsolidated companies | ||||||||||||||||||||||||||||||||||
gain on sales of long-lived assets | ||||||||||||||||||||||||||||||||||
excess tax benefit from stock-based compensation | ||||||||||||||||||||||||||||||||||
income tax receivable | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities - continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities - discontinued operations | ||||||||||||||||||||||||||||||||||
sale of management rights and intellectual property | ||||||||||||||||||||||||||||||||||
net cash flows from investing activities - continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities - discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows from investing activities | ||||||||||||||||||||||||||||||||||
net borrowings under term loan b | ||||||||||||||||||||||||||||||||||
proceeds from the issuance of common stock, net of issuance costs of 1,131 | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities - continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities - discontinued operations | ||||||||||||||||||||||||||||||||||
(income) income from discontinued operations, net of taxes | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities - continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities - continuing operations | ||||||||||||||||||||||||||||||||||
income from discontinued operations, net of taxes | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities - discontinued operations | ||||||||||||||||||||||||||||||||||
(gain) income from discontinued operations, net of taxes | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities—continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities—discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows from investing activities—continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities—discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities—continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities—discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities—continuing operations | ||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of issuance cost of 1,131 | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities—discontinued operations | ||||||||||||||||||||||||||||||||||
write-off of deferred financing costs related to senior notes | ||||||||||||||||||||||||||||||||||
write-off of deferred financing costs related to credit facility | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities – continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities – discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities – continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities – discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities – continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities – discontinued operations | ||||||||||||||||||||||||||||||||||
write-off of deferred financing costs related to refinancing of credit facility | ||||||||||||||||||||||||||||||||||
net gain on extinguishment of debt | ||||||||||||||||||||||||||||||||||
loss on assets damaged in flood | ||||||||||||||||||||||||||||||||||
changes in | ||||||||||||||||||||||||||||||||||
net cash flows from investing activities – continuing operations | ||||||||||||||||||||||||||||||||||
repurchases of senior notes | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities – discontinued operations | ||||||||||||||||||||||||||||||||||
loss on disposals of long-lived assets | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities — continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from operating activities — discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities — continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows used in investing activities — discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities — continuing operations | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities — discontinued operations | ||||||||||||||||||||||||||||||||||
cash and cash equivalents — unrestricted, beginning of period | ||||||||||||||||||||||||||||||||||
cash and cash equivalents — unrestricted, end of period | ||||||||||||||||||||||||||||||||||
repayments under credit facility | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities—continuing operations | ||||||||||||||||||||||||||||||||||
(income) income from unconsolidated companies | ||||||||||||||||||||||||||||||||||
loss on sales of long-lived assets | ||||||||||||||||||||||||||||||||||
proceeds from the issuance of convertible notes, net of equity-related issuance costs of 1,881 | ||||||||||||||||||||||||||||||||||
purchase of convertible note hedge | ||||||||||||||||||||||||||||||||||
proceeds from the issuance of common stock warrants | ||||||||||||||||||||||||||||||||||
proceeds from the issuance of common stock, net of issuance costs of 5,499 | ||||||||||||||||||||||||||||||||||
purchases of treasury stock | ||||||||||||||||||||||||||||||||||
proceeds from the termination of an interest rate swap on senior notes | ||||||||||||||||||||||||||||||||||
decrease in restricted cash and cash equivalents | ||||||||||||||||||||||||||||||||||
insurance proceeds receivable | ||||||||||||||||||||||||||||||||||
net cash flows from financing activities — continuing operations | ||||||||||||||||||||||||||||||||||
income tax receivable receivable | ||||||||||||||||||||||||||||||||||
net cash flows from investing activities — discontinued operations | ||||||||||||||||||||||||||||||||||
net (repayments) borrowings under credit facility | ||||||||||||||||||||||||||||||||||
purchases of company’s common stock | ||||||||||||||||||||||||||||||||||
net cash flows used in financing activities — discontinued operations | ||||||||||||||||||||||||||||||||||
loss on impaired assets damaged in flood | ||||||||||||||||||||||||||||||||||
termination of interest rate swap on senior notes | ||||||||||||||||||||||||||||||||||
loss (income) from unconsolidated companies | ||||||||||||||||||||||||||||||||||
unrealized gain on viacom stock and cbs stock and related derivatives | ||||||||||||||||||||||||||||||||||
gain on sale of investment in bass pro | ||||||||||||||||||||||||||||||||||
proceeds from sale of investment in bass pro | ||||||||||||||||||||||||||||||||||
deposit on potential acquisition of business | ||||||||||||||||||||||||||||||||||
proceeds from the issuance of convertible notes, net of equity-related issuance costs of 1,893 | ||||||||||||||||||||||||||||||||||
loss (income) from discontinued operations, net of taxes | ||||||||||||||||||||||||||||||||||
gain on extinguishment of debt | ||||||||||||||||||||||||||||||||||
loss on sales of assets | ||||||||||||||||||||||||||||||||||
net cash flows used in operating activities — discontinued operations | ||||||||||||||||||||||||||||||||||
net cash flows used in operating activities — continuing operations | ||||||||||||||||||||||||||||||||||
gain from discontinued operations, net of taxes | ||||||||||||||||||||||||||||||||||
writeoff of deferred financing costs | ||||||||||||||||||||||||||||||||||
gain on sales of assets | ||||||||||||||||||||||||||||||||||
dividends received from investments in unconsolidated companies | ||||||||||||||||||||||||||||||||||
investments in unconsolidated companies | ||||||||||||||||||||||||||||||||||
returns of investment in unconsolidated companies | ||||||||||||||||||||||||||||||||||
proceeds from sales of assets | ||||||||||||||||||||||||||||||||||
collection of note receivable | ||||||||||||||||||||||||||||||||||
repayment of long-term debt | ||||||||||||||||||||||||||||||||||
decrease (increase) in restricted cash and cash equivalents | ||||||||||||||||||||||||||||||||||
income taxes payable | ||||||||||||||||||||||||||||||||||
investment in unconsolidated companies | ||||||||||||||||||||||||||||||||||
borrowings under credit facility | ||||||||||||||||||||||||||||||||||
unrealized (gain) loss on viacom stock and cbs stock and related derivatives | ||||||||||||||||||||||||||||||||||
(gain) loss on sales of assets | ||||||||||||||||||||||||||||||||||
deposit on potential acquisiton of business | ||||||||||||||||||||||||||||||||||
purchases of short-term investments | ||||||||||||||||||||||||||||||||||
proceeds from sale of short term investments | ||||||||||||||||||||||||||||||||||
(repayments) borrowings under credit facility | ||||||||||||||||||||||||||||||||||
returns of investment (additional investment) in unconsolidated companies | ||||||||||||||||||||||||||||||||||
acquisition of businesses, net of cash acquired | ||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | ||||||||||||||||||||||||||||||||||
returns of investments in unconsolidated companies | ||||||||||||||||||||||||||||||||||
dividends received from investment in rhac holdings, llc | ||||||||||||||||||||||||||||||||||
investment in rhac holdings, llc | ||||||||||||||||||||||||||||||||||
unrealized gain on viacom stock and related derivatives | ||||||||||||||||||||||||||||||||||
gain on sale of assets | ||||||||||||||||||||||||||||||||||
loss on sale of first resort software assets | ||||||||||||||||||||||||||||||||||
cash of business acquired | ||||||||||||||||||||||||||||||||||
returns of investment in rhac holdings, llc | ||||||||||||||||||||||||||||||||||
proceeds from sale of assets | ||||||||||||||||||||||||||||||||||
proceeds from sale of short-term investments | ||||||||||||||||||||||||||||||||||
decrease (increase) in cash and cash equivalents — restricted | ||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options and stock purchase plans | ||||||||||||||||||||||||||||||||||
net change in cash and cash equivalents — unrestricted | ||||||||||||||||||||||||||||||||||
cash and cash equivalents — unrestricted, beginning of year | ||||||||||||||||||||||||||||||||||
cash and cash equivalents — unrestricted, end of | ||||||||||||||||||||||||||||||||||
year | ||||||||||||||||||||||||||||||||||
unrealized loss on viacom stock and related derivatives | ||||||||||||||||||||||||||||||||||
purchase of investment in rhac holdings, llc | ||||||||||||||||||||||||||||||||||
cumulative effect of accounting change, net of taxes | ||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents — restricted | ||||||||||||||||||||||||||||||||||
cash and cash equivalents — unrestricted, end of year | ||||||||||||||||||||||||||||||||||
income tax refund received | ||||||||||||||||||||||||||||||||||
net cash flows from investing activities - discontinued operations | ||||||||||||||||||||||||||||||||||
gain on discontinued operations, net of taxes | ||||||||||||||||||||||||||||||||||
unrealized (gain) loss on viacom stock and related derivatives | ||||||||||||||||||||||||||||||||||
net cash flows used in operating activities - discontinued operations | ||||||||||||||||||||||||||||||||||
sale of assets |
We provide you with 20 years of cash flow statements for Ryman Hospitality Properties stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ryman Hospitality Properties stock. Explore the full financial landscape of Ryman Hospitality Properties stock with our expertly curated income statements.
The information provided in this report about Ryman Hospitality Properties stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.